MLKL-IN-2 |
| Katalog-Nr.GC63680 |
MLKL-IN-2 ist ein MLKL-Inhibitor, extrahiert aus dem Patent WO2021224505A1, Verbindung (i).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 899759-16-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
MLKL-IN-2 is a MLKL inhibitor extracted from patent WO2021224505A1, compound (i)[1].
[1]. SÁez AJG, et, al. Modulation of mixed lineage kinase domain-like protein signaling. WO2021224505A1.
Review for MLKL-IN-2
Average Rating: 5 (Based on Reviews and 32 reference(s) in Google Scholar.)
Review for MLKL-IN-2
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *